Being in the vanguard of technological advances allows us for effective identification of promising opportunities in the biotechnology sector. Focusing on innovation is our way of operating. Innovation for Σellas is not an abstract concept: it is an everyday practice. A practice ensured by strict discipline and a systematic approach in order to achieve breakthrough developments, novel treatments and optimal products that will considerably improve the lives of patients worldwide.
Our success is assured by our highly educated multi-disciplinary team of professionals: executive management with a superb track-record in the healthcare industry, physicians of all medical specializations (invasive and non-invasive), a dedicated group of study coordinators, study nurses, project managers, data managers, regulatory experts, analysts, clinical pharmacologists and toxicologists, all trained according to ICH-GCP guidelines.
By keeping an open-mind and being passionate about the identification of disruptive and break-through technologies in the global healthcare industry, Σellas reaches out through its global network of experienced and dedicated professionals and organisations to strengthen the Group’s overall business health platform, the center-piece being the patient.